Genome-scale CRISPR activation screen uncovers tumor-intrinsic modulators of CD3 bispecific antibody efficacy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genome-scale CRISPR activation screen uncovers tumor-intrinsic modulators of CD3 bispecific antibody efficacy
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-27
DOI
10.1038/s41598-019-56670-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bispecific Antibodies in the Treatment of Hematologic Malignancies
- (2019) Johannes Duell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A chemo-enzymatically linked bispecific antibody retargets T cells to a sialylated epitope on CD43 in acute myeloid leukemia
- (2019) Lina Bartels et al. CANCER RESEARCH
- The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation
- (2019) Poshmaal Dhar et al. Frontiers in Cellular and Infection Microbiology
- Prognostic and therapeutic role of CLEC12A in acute myeloid leukemia
- (2018) Linde M. Morsink et al. BLOOD REVIEWS
- Recent advances of bispecific antibodies in solid tumors
- (2017) Shengnan Yu et al. Journal of Hematology & Oncology
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Harnessing T cells to fight cancer with BiTE®antibody constructs - past developments and future directions
- (2016) Matthias Klinger et al. IMMUNOLOGICAL REVIEWS
- Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity
- (2016) Andrew D. Tustian et al. mAbs
- Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis
- (2016) Kana Hasegawa et al. PLoS One
- T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts
- (2016) Judith Feucht et al. Oncotarget
- Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment
- (2015) G. Zugmaier et al. BLOOD
- CD43 expression in diffuse large B-cell lymphoma, not otherwise specified: CD43 is a marker of adverse prognosis
- (2015) Xiao-Bo Ma et al. HUMAN PATHOLOGY
- CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo
- (2015) Francisco Velázquez et al. JOURNAL OF IMMUNOLOGY
- Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells
- (2015) Shuying Chen et al. LEUKEMIA RESEARCH
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk
- (2015) Kimberly H. Harrington et al. PLoS One
- T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330
- (2015) G S Laszlo et al. Blood Cancer Journal
- A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys
- (2015) Eric J. Smith et al. Scientific Reports
- Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia
- (2014) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes
- (2014) L. E. Macdonald et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
- (2014) A. J. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma
- (2013) Zdravko Mitrovic et al. BRITISH JOURNAL OF HAEMATOLOGY
- Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing
- (2013) Caroline B. Madsen et al. PLoS One
- T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival
- (2012) Mary C. Clark et al. Annals of the New York Academy of Sciences
- Galectin-1 promotes human neutrophil migration
- (2012) C. Auvynet et al. GLYCOBIOLOGY
- MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis
- (2012) Shigeru Tsuboi INTERNATIONAL JOURNAL OF ONCOLOGY
- Costimulatory and coinhibitory receptors in anti-tumor immunity
- (2009) Gregory Driessens et al. IMMUNOLOGICAL REVIEWS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started